ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink advanced liver tumors
Disease control Not yet recruitingThis study tests a new drug, WGI-0301, combined with lenvatinib in 80 adults with advanced liver cancer that hasn't responded to first treatment. The goal is to see if the combination can shrink tumors and is safe. Participants will receive both drugs and be monitored for side ef…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New hope for advanced liver cancer: experimental combo targets tumors directly
Disease control Not yet recruitingThis study tests a new treatment for people with advanced liver cancer that has not improved after initial therapy. The treatment delivers a chemotherapy drug directly into the liver's blood supply, combined with other medications given through the body. The goal is to see if thi…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1, PHASE2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
New study tracks immune drug success in advanced liver cancer
Knowledge-focused Not yet recruitingThis study looks at how well immune checkpoint inhibitors work for people with advanced liver cancer. Researchers will track survival times in 75 adults already receiving these drugs as part of their regular care. The goal is to understand real-world outcomes, not to test a new t…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Sponsor: Ahmed Karam Helmy • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC